Rejeski K, Wang Y, Albanyan O, Munoz J, et al. The CAR-HEMATOTOX score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene autoleucel for relapsed or refractory MCL. Am J Hematol 2023;98:1699-1710.
PMID: 37584447